China Innovation Investment Limited Profile Avatar - Palmy Investing

China Innovation Investment Limited

China Innovation Investment Limited invests in equity-related securities and debt instruments in listed and unlisted companies in Hong Kong and the People's Republic of China. It also engages in transactions comprising options and futures that are traded…

Asset Management
HK, Sheung Wan [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth n.A. n.A.
Leverage & Liquidity 17% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q2 Δ in %
EV/EBITDA 13.71 -16.04 -18.59
Graham Fair Price -8.97 0.02 0.02
PEG inf 0.00 -0.06
Price/Book -1.23 0.23 0.23
Price/Cash Flow -42.15 1.71 2.95
Prices/Earnings 22.19 7.91 -6.47
Price/Sales -80.26 21.67 -109.79
Price/FCF -42.15 1.71 2.95
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q2 Δ in %
Gross Profit Margin -8.24 0.92 1.00
Operating Margin -84.97 0.68 4.55
ROA -19.07 < 0.005 < 0.005
ROE < 0.005 < 0.005 -19.17
ROIC < 0.005 < 0.005 -24.49
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q2 Δ in %
Debt QOQ 0.00 0.62 inf
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -1.00 0.00 inf
EPS QOQ -1.00 0.00 inf
FCF QOQ 1.56 0.00 inf
Revenue QOQ -2.23 0.00 inf
Naive Interpretation member
03 - Financial Growth · Not Interpreted
Fundamentals

Leverage & Liquidity

Metric Q4 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) -145.19 0.00 inf
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization < 0.005 0.00 inf
Quick Ratio 153.84 354.97 130.74
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q2 Δ in %
Book Value 0.04 0.04 1.25
Cash 0.01 0.02 39.41
Capex < 0.005 0.00 inf
Free Cash Flow < 0.005 < 0.005 72.85
Revenue < 0.005 < 0.005 406.69
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q2 Δ in %
Current Ratio 288.65 354.97 22.98
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 7.95 -47.53 497.86
Naive Interpretation Member
06 - Financial Health · Bad
End of 1217.HK's Analysis
CIK: - CUSIP: G2112R104 ISIN: KYG2112R1048 LEI: - UEI: -
Secondary Listings
1217.HK has no secondary listings inside our databases.